National Healthcare Corp

National Healthcare Corp(NHC)股票分析

$235.600

-11.733 (-4.98%)收盤時

Loading chart…
最高
248.200
開盤
247.940
成交量加權均價
239.16
成交量
116.49K
市值
1.66B
最低
233.680
成交金額
27.86M
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages approximately 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies.

AI 分析 of National Healthcare Corp (NHC)

買進

National Healthcare Corp is a good buy right now due to its impressive earnings growth and strong revenue momentum. The current price is $242.82, with a forward P/E ratio of 9.89, indicating that the stock is undervalued relative to its earnings potential. Additionally, the company reported a gross margin of 37.98% in Q2 2026, showcasing its operational efficiency. However, the RSI is at 73.92, suggesting that the stock may be overbought in the short term, which is a risk to consider.

估值指標

National Healthcare Corp(NHC)目前預期本益比為 9.89,5 年平均預期本益比為 1.69。

預期本益比

嚴重高估
5 年均值 P/E
1.69
目前P/E
9.89
高估
5.59
低估
-2.20

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 NHC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%NHC

$104.57

情境價格

基

基準

基準 · 50%NHC

$86.97

情境價格

悲

悲觀

悲觀 · 25%NHC

$67.53

情境價格

持有 NHC 的大戶

W

Washington H. Soul Pattinson and Company Limited

+ 持有NHCPEN

-8.82%

3個月報酬率

事件時間軸

2026-08-07 (ET)

07:30:00

Q2 Revenue Reaches $408M vs $375M Last Year

2026-05-08 (ET)

07:11:00

Q1 Revenue Reaches $381.8M

2026-05-07 (ET)

16:50:00

National HealthCare Corporation Increases Quarterly Dividend to $0.67

2026-04-21 (ET)

16:50:00

National HealthCare to Acquire 32 Nursing Facilities for $560M

2025-05-08 (ET)

16:45:53

National Healthcare announces 4.9% increase in quarterly common dividend to 64c

資訊

NHC 常見問題 —— 由 Alphio AI 解答

National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages approximately 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. It operates in the Healthcare sector (SERVICES-SKILLED NURSING CARE FACILITIES industry).

National Healthcare Corp is a good buy right now due to its impressive earnings growth and strong revenue momentum. The current price is $242.82, with a forward P/E ratio of 9.89, indicating that the stock is undervalued relative to its earnings potential. Additionally, the company reported a gross margin of 37.98% in Q2 2026, showcasing its operational efficiency. However, the RSI is at 73.92, suggesting that the stock may be overbought in the short term, which is a risk to consider.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易